LI Xi, FU Fang, WANG Qin, TONG Guang-zhi. Serological surveillance and analysis of avian influenza in free-living birds in Guangxi and Hubei provinces of China in 2004. Chinese Journal of Veterinary Medicine
Abstract: Hemagglutin inInhibition test is used in this study to monitor the 54 serum samples from healthy hawks, pigeons and quails in the eco system in Hubei and Guangxi province, where there were outbreaks of H5 subtype HPAI in 2004. In addition, the data are statistically analyzed. The results show that the positive rates of anti, H9 subtype, H6 subtype aiv and H5 subtype aiv antibodies is 64. 8%、75. 9% and 29.6% respectively. According to these results, we drew the conclusion that H9 sub type aiv, H6 sub type aiv and H5 sub type aiv circulated around this eco system. And H9 subtype aiv and H6 subtype aiv circulated stably and chronically in this eco system and are the leading prevalent serotype. On the other hand, the positive
rate of anti H5 subtype aiv antibodies is 29. 6% , the highest titer of antibodies of that is 640 ×. It is impossible that the H5 subtype aiv is newly transmitted into the eco system or a new recombinant strain of virus. And it is correlated to the outbreaks at this time there, which need to be validated at a molecular level.
Key words: eco system; antibody anti aiv; Hemagglutinin Inhibition test; statistics
Fulltext can be downloaded at Chinese version of F.I.C
See Also:
Latest articles in those days:
- Sequence-based epitope mapping of high pathogenicity avian influenza H5 clade 2.3.4.4b in Latin America 8 hours ago
- Guanylate-binding protein 1 inhibits inflammatory factors produced by H5N1 virus through Its GTPase activity 8 hours ago
- Evidence of reassortment of avian influenza A (H2) viruses in Brazilian shorebirds 2 days ago
- Epitopes in the HA and NA of H5 and H7 avian influenza viruses that are important for antigenic drift 3 days ago
- Assessment of CD8+ T-cell mediated immunity in an influenza A(H3N2) human challenge model in Belgium: a single centre, randomised, double-blind phase 2 study 3 days ago
[Go Top] [Close Window]